Akebia Therapeutics, Inc. (AKBA)
0.9001
-0.01
(-0.72%)
USD |
NASDAQ |
Aug 24, 16:00
0.9001
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Total Liabilities (Quarterly) : 324.64M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 324.64M |
| March 31, 2026 | 335.14M |
| December 31, 2025 | 343.96M |
| September 30, 2025 | 322.56M |
| June 30, 2025 | 316.37M |
| March 31, 2025 | 285.60M |
| December 31, 2024 | 269.86M |
| September 30, 2024 | 257.54M |
| June 30, 2024 | 253.95M |
| March 31, 2024 | 252.74M |
| December 31, 2023 | 272.29M |
| September 30, 2023 | 274.42M |
| June 30, 2023 | 280.52M |
| March 31, 2023 | 291.21M |
| December 31, 2022 | 350.82M |
| September 30, 2022 | 422.04M |
| June 30, 2022 | 459.50M |
| March 31, 2022 | 509.24M |
| December 31, 2021 | 455.34M |
| September 30, 2021 | 465.12M |
| June 30, 2021 | 437.23M |
| March 31, 2021 | 414.81M |
| December 31, 2020 | 396.52M |
| September 30, 2020 | 358.18M |
| June 30, 2020 | 374.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 391.36M |
| December 31, 2019 | 376.44M |
| September 30, 2019 | 327.66M |
| June 30, 2019 | 304.17M |
| March 31, 2019 | 324.41M |
| December 31, 2018 | 473.39M |
| September 30, 2018 | 261.28M |
| June 30, 2018 | 247.86M |
| March 31, 2018 | 245.62M |
| December 31, 2017 | 241.85M |
| September 30, 2017 | 238.71M |
| June 30, 2017 | 279.82M |
| March 31, 2017 | 228.64M |
| December 31, 2016 | 232.10M |
| September 30, 2016 | 68.41M |
| June 30, 2016 | 62.35M |
| March 31, 2016 | 53.68M |
| December 31, 2015 | 11.94M |
| September 30, 2015 | 14.18M |
| June 30, 2015 | 5.913M |
| March 31, 2015 | 8.85M |
| December 31, 2014 | 6.917M |
| September 30, 2014 | 6.556M |
| June 30, 2014 | 4.806M |
| March 31, 2014 | 6.161M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | 775.40M |
| Exelixis, Inc. | 650.47M |
| ADMA Biologics, Inc. | 276.00M |
| Arcutis Biotherapeutics, Inc. | 267.96M |
| Relay Therapeutics, Inc. | 77.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 349.66M |
| Shareholders Equity (Quarterly) | 25.02M |
| Debt to Equity Ratio | 8.426 |
| Current Ratio | 1.427 |
| Net Debt Paydown Yield | -0.30% |